Get started
Author

Taylor Galloway

Observed names: T M Galloway, Taylor M Galloway, Taylor M. Galloway
ORCID: 0009-0000-3396-6168
Observed ORCID: 0009-0000-3396-6168
OpenAlex ID: A5104342131
Supc-01 Use of the Selective Plasma Kallikrein Inhibitor Rz402 for Stabilization of Cerebral Edema Related to Metastatic Melanoma – Results of a Single Patient Protocol
2026 · Ugur Sener, Sydney Schultz, et al. · Neuro-Oncology Advances
PDF
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiation
2026 · Ugur Sener, Bryan Neth, et al. · Contemporary Clinical Trials Communications
Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience
2026 · Sofia Rael, Bryan J Neth, et al. · Neuro-Oncology Practice
Protocol for neuro-oncology anywhere 242: Pilot study evaluating telehealth and in-person assessments in patients with glioma receiving oral chemotherapy
2025 · Ugur Sener, Taylor Galloway, et al. · Contemporary Clinical Trials Communications
NCOG-27. Neuro-oncology anywhere: A fully decentralized clinical trial evaluating cognitive assessments and interventions for patients who received intracranial radiation therapy
2025 · Ugur Sener, Bryan Neth, et al. · Neuro-Oncology
PDF
QOL-12. Patient and caregiver priorities in neuro-oncology care
2025 · Lauren Webb, Julie Reiland, et al. · Neuro-Oncology
PDF
INNV-26. Neuro-oncology anywhere (NOA) 242: Interim results from a pragmatic clinical trial evaluating telehealth versus in-person evaluations for individuals with glioma undergoing oral chemotherapy
2025 · Ugur Sener, Taylor Galloway, et al. · Neuro-Oncology
PDF
P17.34.b Belzutifan in Clinical Practice: Outcomes and Safety in a Real-world Cohort of Patients With Vhl-associated Neoplasms
2025 · M H Ser, T M Galloway, et al. · Neuro-Oncology
PDF
Telehealth utilization in neuro-oncology: A single institution experience.
2025 · Hazal Ser, Taylor Galloway, et al. · Journal of Clinical Oncology
PDF
Neuro-oncology anywhere: Preliminary results from a decentralized clinical trial aimed at improving neurocognitive outcomes in patients with CNS malignancy.
2025 · Bryan Neth, Eva Alden, et al. · Journal of Clinical Oncology
Neuro-oncology anywhere 242: Pilot study evaluating telehealth and in-person assessments in patients with glioma receiving oral chemotherapy—Clinical trial in progress.
2025 · Ugur Sener, Taylor Galloway, et al. · Journal of Clinical Oncology
PDF
When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?—a critical review of LITESPARK-004 results
2025 · Ugur Sener, Taylor Galloway · Translational Cancer Research
569 Improving communication and collaboration: Strategies for reducing non-accruing trials
2025 · Rosalean Rock Ruby, Taylor Galloway, et al. · Journal of Clinical and Translational Science
PDF
563 Optimize efficiency in clinical trial development by assessing and forecasting operationally associated risks utilizing REDCap
2025 · David Harwood, Laura N. Hanson, et al. · Journal of Clinical and Translational Science
PDF
564 Digital pill diaries in an electronic health record system: Enhancing chemotherapy adherence monitoring in decentralized clinical trials
2025 · Taylor Galloway, Karen Konzen, et al. · Journal of Clinical and Translational Science
PDF
Neuro-oncology anywhere: A decentralized approach to clinical trials in brain tumors and beyond.
2024 · Bryan Neth, Mason Webb, et al. · Journal of Clinical Oncology
526 Administrative Simplification of Committee Reviews through REDCap
2024 · Taylor Galloway, Laura Hanson, et al. · Journal of Clinical and Translational Science
PDF
Works count: 17
Citation count:
H-index:
I10-index:
Year
Topic
Type